More TheraVitae Press Attention
(From Reuters AlertNet). One can hope that ever more attention given to successful commercialization of stem cell therapies outside the US will lead to some reduction in stifling regulation within the US. Certainly advocacy groups - such as FasterCures - should be making hay with the success of TheraVitae. "Theravitae is set to begin clinical trials with Thai doctors in January to treat peripheral vascular disease, a circulatory ailment which can lead to amputations. Next up: Parkinson's disease by mid-2006 and some forms of blindness in the first quarter of 2007. Eventually, Theravitae thinks, the technology could be used to treat emphysema, broken bones, renal failure and diabetes. ... Theravitae, which says it will become profitable in January 2006, expects 100 people a month will be coming to Thailand to seek the stem cell treatment by June next year."